“This year didn’t start out with a bang for these two biotechs, but their performances over the past few months have been breathtaking,” observes the author of today’s article in regards to the two small-cap biotech stocks he proceeds to highlight – which have posted gains this year of 1,080% and 618%, respectively. What’s behind these tremendous gains – and are either of these two stocks buys right now? CLICK HERE.